Transplanting stem cells to a diseased retina may be a method of treating certain common eye disorders in the future. In her dissertation, Lund scientist Anita Blixt Wojciechowski reports research findings that enhance the knowledge needed to make this treatment possible.
Retinitis pigmentosa is a hereditary retinal disease that affects one person in 3,500 and leads to severe vision impairment or blindness. Age-related deterioration of the yellow spot, the part of the retina that is most crucial to sharp vision, is another common cause of vision impairment. This disease (age related macular disease) affects nearly a third of all people over the age of 75. Today there is no good treatment for either disease.
Anita Blixt Wojciechowskis research involves transplanting fetal stem cells from rats to the eyes of adult rats. She has experienced both success and failure in her work.
Ingela Björck | alfa
The end of pneumonia? New vaccine offers hope
23.10.2017 | University at Buffalo
Scientists track ovarian cancers to site of origin: Fallopian tubes
23.10.2017 | Johns Hopkins Medicine
23.10.2017 | Event News
17.10.2017 | Event News
10.10.2017 | Event News
23.10.2017 | Life Sciences
23.10.2017 | Physics and Astronomy
23.10.2017 | Health and Medicine